Cellectar Biosciences Inc (CLRB) — Net Asset Quality Index
Cellectar Biosciences Inc (CLRB) has a Net Asset Quality Index of 66.2% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $14.98 Million minus total liabilities of $5.06 Million yields net assets of $9.92 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check CLRB financial resilience to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Cellectar Biosciences Inc Net Asset Quality Index Over Time (2004–2025)
This chart shows how Cellectar Biosciences Inc's Net Asset Quality Index has evolved across 22 annual periods from 2004 to 2025. As of December 2025, the index stands at 66.2%, representing net assets of $9.92 Million against total assets of $14.98 Million USD. See working capital to net assets of Cellectar Biosciences Inc to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Cellectar Biosciences Inc (2004–2025)
The table below presents the year-by-year Net Asset Quality Index for Cellectar Biosciences Inc from 2004 to 2025, covering 22 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see CLRB company net worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 66.2% | $9.92 Million | $14.98 Million | $5.06 Million | ▲ +10.1 pp |
| 2024 | 56.1% | $14.29 Million | $25.47 Million | $11.18 Million | ▲ +170.2 pp |
| 2023 | -114.1% | $-13.78 Million | $12.08 Million | $25.85 Million | ▼ -158.3 pp |
| 2022 | 44.2% | $9.54 Million | $21.59 Million | $12.05 Million | ▼ -44.7 pp |
| 2021 | 88.8% | $33.05 Million | $37.20 Million | $4.16 Million | ▼ -4.6 pp |
| 2020 | 93.4% | $54.79 Million | $58.66 Million | $3.86 Million | ▲ +19.5 pp |
| 2019 | 73.9% | $9.06 Million | $12.25 Million | $3.19 Million | ▼ -14.1 pp |
| 2018 | 88.1% | $13.26 Million | $15.05 Million | $1.79 Million | ▲ +4.5 pp |
| 2017 | 83.6% | $10.75 Million | $12.87 Million | $2.12 Million | ▼ -4.8 pp |
| 2016 | 88.4% | $13.54 Million | $15.32 Million | $1.78 Million | ▲ +66.6 pp |
| 2015 | 21.7% | $1.65 Million | $7.60 Million | $5.95 Million | ▼ -58.4 pp |
| 2014 | 80.1% | $10.75 Million | $13.42 Million | $2.67 Million | ▲ +55.1 pp |
| 2013 | 24.9% | $1.70 Million | $6.82 Million | $5.12 Million | ▼ -63.6 pp |
| 2012 | 88.5% | $10.16 Million | $11.48 Million | $1.32 Million | ▼ -1.3 pp |
| 2011 | 89.8% | $9.48 Million | $10.56 Million | $1.08 Million | ▲ +40.7 pp |
| 2010 | 49.0% | $1.21 Million | $2.46 Million | $1.25 Million | ▲ +350.2 pp |
| 2009 | -301.1% | $-26.90 Million | $8.93 Million | $35.83 Million | ▲ +79.8 pp |
| 2008 | -380.9% | $-5.58 Million | $1.47 Million | $7.05 Million | ▼ -328.1 pp |
| 2007 | -52.8% | $-5.87 Million | $11.11 Million | $16.98 Million | ▼ -141.8 pp |
| 2006 | 89.0% | $10.61 Million | $11.92 Million | $1.31 Million | ▼ -6.6 pp |
| 2005 | 95.6% | $4.72 Million | $4.94 Million | $217.16K | ▲ +4101.2 pp |
| 2004 | -4005.6% | $-4.35 Million | $108.57K | $4.46 Million | — |